Brandon Capital Partners
Venture capitalMelbourne · Seed–Growth · 1 people tracked
Find your way into Brandon Capital Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Kip Dudgeon to introduce you to Chris Smith
You →Kip · together at Brandon Capital Partners →Chris
Sign up to find every way you can get introduced to Brandon Capital Partners
- Your email: who you already know at Brandon Capital Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Brandon Capital Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Brandon Capital is a life sciences venture capital firm that invests in biotech and medical research companies, with investors and venture partners across Australia, New Zealand, the United States and the United Kingdom.
Source: firm website, verified Sep 20, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 6 of 7 portfolio companiesBiotech ×6Medical Devices ×4Digital Health ×3Healthtech ×3Deep Tech ×2Impact & Social Good ×1Longevity ×1
HQs:Australia×3United States×2United Kingdom×1
Investments · 7 tracked
founders shown can be your intro pathAmaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.
Biotech
Co-investorsBooster Innovation FundCure Kids VenturesTenmile
Brandon BioCatalyst funds biomedical development opportunities associated with its Member Institutes, offering investments ranging from AU$500,000 to AU$30 million across stages from proof-of-concept to late-stage technologies.
BiotechDeep TechDigital HealthHealthtechImpact & Social GoodMedical Devices
George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health.
BiotechDigital HealthHealthtechMedical Devices
Mark Mallon(Chief Executive Officer)inProfessor Anthony Rodgers(Chief Medical Officer)Dr Karl Roberts(Chief Operating Officer)in
Co-investorsBrandon BioCatalyst
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)inCasey Cunningham(Director)Leighton Read(Director)inBob Soh(Director)in
Co-investorsBrandon BioCatalystBreakout Labs
Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment.
BiotechMedical DevicesLondon, GB
Co-investorsNovo HoldingsSofinnova PartnersAbingworth
An online gambling platform licensed under Curacao eGaming, offering video slots, live dealer tables, progressive jackpots, and specialty games from studios such as NetEnt, Microgaming, and Pragmatic Play.
Co-investorsStoic VCBrandon BioCatalyst
Brandon Capital is a venture capital firm that transforms medical research breakthroughs into therapeutic products, supporting life science companies from early-stage through commercialization.
BiotechMedical DevicesSan Francisco, US
Co-investorsBrandon BioCatalystAirTree VenturesGolden Gate Ventures
Portfolio news
latest coverage across their companiesMyricx Bio · techfundingnews.com · Jul 6, 2026
Frequently asked questions
- How many investments has Brandon Capital Partners made?
- Brandon Capital Partners has 7 tracked investments.
- What stage does Brandon Capital Partners invest at?
- Brandon Capital Partners invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Brandon Capital Partners focus on?
- Brandon Capital Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Brandon Capital Partners located?
- Brandon Capital Partners is headquartered in Melbourne, AU.
- Who does Brandon Capital Partners co-invest with?
- Brandon Capital Partners most often shares deals with Brandon BioCatalyst, Novo Holdings, Sofinnova Partners, among 3 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.



















.jpeg)
